• Campylobacter jejuni Antibody, IgG
  • Smith (ENA) Antibody, IgG
  • Lyme Disease (Borrelia burgdorferi) Antibody, IgG, IgM, Immunoblot
  • Proinsulin, Intact
  • Pentazocine, Urine
  • GRACILE Syndrome
  • Squamous Cell Carcinoma Antigen (SSCA)
  • Cadmium, Urine
  • Buprenorphine, Screen, Urine
  • Haemophilus ducreyi, Molecular Method, PCR
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Overview
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.